Pharmacological characterisation of JNJ‐78911118, a novel, centrally‐penetrant, selective GluN2A antagonist
Sign Up to like & getrecommendations! Published in 2025 at "British Journal of Pharmacology"
DOI: 10.1111/bph.70069
Abstract: Non‐selective NMDA receptor antagonism produces rapid symptom improvement in treatment‐resistant depression; however, associated side effects necessitate medical oversight during administration. We hypothesised that selective GluN2A antagonism could provide similar efficacy with an improved side effect… read more here.
Keywords: characterisation jnj; pharmacology; jnj 78911118; pharmacological characterisation ... See more keywords